Synthesis of emodin derivatives and their inhibiting effects on proliferation of leukemia cell lines.
10.7534/j.issn.1009-2137.2013.01.012
- Author:
Jun-Ting ZHENG
1
;
Wen-Feng WANG
;
Jing LI
;
Zhi-Hong ZHENG
;
Ting-Bo LIU
;
Jian-Da HU
Author Information
1. Fujian Medical University, Fujian Province, China.
- Publication Type:Journal Article
- MeSH:
Cell Proliferation;
drug effects;
Emodin;
analogs & derivatives;
pharmacology;
Humans;
K562 Cells;
Leukemia;
pathology
- From:
Journal of Experimental Hematology
2013;21(1):53-56
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this study was to explore the inhibitory effect of newly synthesised emodin derivatives on the proliferation of leukemia cell lines and to select the most effective one from these emodin derivatives for further research. Emodin derivatives were synthesized by modifying the structure of emodin. MTT method was used to detect the proliferative inhibition in leukemia cell lines treated with emodin derivatives. The results showed that the half inhibitory concentration (IC50) for K562 cells treated with emodin derivatives E10-19 for 48 h was 0.84 - 12.01 µmol/L. E19 displayed the best anti-proliferative activity, while E16 and E17 did not show effects on K562 cells. Emodin derivative E19 was chosen for treating U937, NB4, Molt-4 and CA-46 cells, their IC50 for 48 h were 0.85, 0.9, 0.76, 0.8 µmol/L respectively. The IC50 of E19 for LQ2 cells was 3.60 µmol/L, and the IC50 range of E19 for normal human peripheral blood mononuclear cells at 48 h was 4.01 - 4.78 µmol/L. It is concluded that emodin derivative E19 can strongly inhibit the growth of leukemia cells and its inhibiting effect on proliferation of leukemia cells has a certain specificity. The specific mechanism of E19 anti-leukemia effect should be further studied.
